| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.094 | 0.002 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.002 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.002 |
| mRNA | StemRegenin 1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.096 | 0.002 |
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.096 | 0.003 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.094 | 0.003 |